SCHEMBL19863311

SCHEMBL19863311

N[C@@H](CC(=O)NC(c1ccccc1)(c1ccccc1)c1ccccc1)c1nc(N2CCCCC2)no1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.39
DPP4 P27487 3/20 0.35
DPP7 Q9UHL4 3/20 0.35
PTGS2 P35354 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35
ALDH1A1 P00352 6/20 0.34
TSHR P16473 3/20 0.34
KDM4E B2RXH2 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAPK8 P45983 1/20 0.34
CDC7 O00311 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18077928 0.76 MAPK1 (0.39) DPP4DPP7DPP8DPP9ALDH1A1
SCHEMBL18078035 0.76 MAPK1 (0.39) DPP4DPP7DPP8DPP9ALDH1A1
SCHEMBL19871032 0.76 HCAR2 (0.40) HCAR2DPP4DPP7MAPTBMP1
SCHEMBL18078047 0.75 DPP4 (0.38) DPP4DPP7DPP8DPP9ALDH1A1
SCHEMBL18078058 0.72 DPP4 (0.36) DPP4DPP7DPP8DPP9KDM4E
SCHEMBL28776901 0.69 HCAR2 (0.37) HCAR2
SCHEMBL28776897 0.69 HCAR2 (0.37) HCAR2
SCHEMBL19871039 0.69 ALDH1A1 (0.39) HCAR2ALDH1A1TSHRNPSR1TP53
Hydrochloric Acid SCHEMBL6969599 0.69 S1PR3 (0.42) ALDH1A1TSHRKDM4ENPSR1GAA
Hydrochloric Acid SCHEMBL6969606 0.69 S1PR3 (0.42) ALDH1A1TSHRKDM4ENPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180044329-A1 3-SUBSTITUTED-1,2,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044329-A1 3-SUBSTITUTED-1,2,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORS PDCD1, CD274, PDCD1LG2 HCAR2 1533/4885DPP4 2031/4885DPP7 2183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.